Wells Fargo
IMCR icon

Wells Fargo’s Immunocore IMCR Stock Holding History

Wells Fargo’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Sell
11,022
-64,451
-85% -$1.91M ﹤0.01% 4857
2026
Q1 		$2.28M Sell
75,473
-1,755
-2% -$56.8K ﹤0.01% 3182
2025
Q4 		$2.68M Sell
77,228
-6,453
-8% -$228K ﹤0.01% 3206
2025
Q3 		$3.04M Buy
83,681
+2,920
+4% +$99.2K ﹤0.01% 3001
2025
Q2 		$2.53M Sell
80,761
-2,909
-3% -$90.4K ﹤0.01% 3030
2025
Q1 		$2.48M Buy
83,670
+11,735
+16% +$352K ﹤0.01% 2993
2024
Q4 		$2.12M Sell
71,935
-11,120
-13% -$352K ﹤0.01% 3147
2024
Q3 		$2.59M Buy
83,055
+1,273
+2% +$46.3K ﹤0.01% 2855
2024
Q2 		$2.77M Sell
81,782
-4,314
-5% -$220K ﹤0.01% 2723
2024
Q1 		$5.6M Buy
86,096
+1,953
+2% +$134K ﹤0.01% 2175
2023
Q4 		$5.75M Buy
84,143
+13,698
+19% +$712K ﹤0.01% 2113
2023
Q3 		$3.66M Buy
70,445
+17,215
+32% +$1.02M ﹤0.01% 2335
2023
Q2 		$3.19M Buy
53,230
+52,834
+13,342% +$3.02M ﹤0.01% 2518
2023
Q1 		$19.6K Sell
396
-431
-52% -$24.2K ﹤0.01% 5648
2022
Q4 		$47.2K Buy
827
+391
+90% +$22K ﹤0.01% 4891
2022
Q3 		$20K Buy
+436
New +$20.8K ﹤0.01% 5396

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Wells Fargo's IMCR Position: Q2 2026 in Review

Wells Fargo reduced its Immunocore (IMCR) stake by 85% in Q2 2026, selling an estimated $1.91M and leaving 11,022 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #4857.

Wells Fargo first reported a position in IMCR in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.75M in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Wells Fargo held 11,022 shares of Immunocore worth $350K as of Q2 2026.
  • Wells Fargo sold 64,451 Immunocore shares in Q2 2026, an estimated $1.91M.
  • Immunocore made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4857 holding.
  • Wells Fargo first reported a position in Immunocore in Q3 2022 and has held it in 16 quarters since.
  • Wells Fargo's Immunocore position peaked at $5.75M in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.